Texas Capital Bank Wealth Management Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$269K Sell
4,428
-678
-13% -$39.5K 0.02% 295
2025
Q4
$275K Buy
+5,106
New +$246K 0.02% 268
2024
Q3
Sell
-31,628
Closed -$1.31M 210
2024
Q2
$1.31M Sell
31,628
-331
-1% -$14.8K 0.14% 68
2024
Q1
$1.73M Sell
31,959
-5
-0% -$255 0.19% 58
2023
Q4
$1.64M Buy
+31,964
New +$1.68M 0.19% 56
2023
Q2
Sell
-3,059
Closed -$212K 233
2023
Q1
$212K Hold
3,059
0.02% 172
2022
Q4
$220K Sell
3,059
-21
-0.7% -$1.58K 0.03% 153
2022
Q3
$219K Sell
3,080
-18
-0.6% -$1.31K 0.03% 130
2022
Q2
$239K Sell
3,098
-95
-3% -$7.24K 0.03% 126
2022
Q1
$233K Sell
3,193
-270
-8% -$18.1K 0.02% 156
2021
Q4
$216K Buy
+3,463
New +$203K 0.02% 151

Other funds holding BMY

Texas Capital Bank Wealth Management Services's BMY Position: Q1 2026 in Review

Texas Capital Bank Wealth Management Services reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q1 2026, selling an estimated $39.5K and leaving 4,428 shares worth $269K. The position accounts for 0.02% of the portfolio, ranked #295.

Texas Capital Bank Wealth Management Services first reported a position in BMY in Q4 2021 and has held it in 11 quarters since. The position peaked at $1.73M in Q1 2024. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Texas Capital Bank Wealth Management Services held 4,428 shares of Bristol-Myers Squibb worth $269K as of Q1 2026.
  • Texas Capital Bank Wealth Management Services sold 678 Bristol-Myers Squibb shares in Q1 2026, an estimated $39.5K.
  • Bristol-Myers Squibb made up 0.02% of Texas Capital Bank Wealth Management Services's portfolio in Q1 2026, its #295 holding.
  • Texas Capital Bank Wealth Management Services first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 11 quarters since.
  • Texas Capital Bank Wealth Management Services's Bristol-Myers Squibb position peaked at $1.73M in Q1 2024.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q1 2026, filed 11 May 2026.